Citius Pharmaceuticals, Inc. (CTXR) Reports Fiscal Full Year 2023 Financial Results and Provides Business...

Mino-Lok® Pivotal Phase 3 trial enrollment completed; topline data expected 2Q 2024 LYMPHIR™ BLA resubmission on track for early 2024 CRANFORD, N.J., Jan. 2, 2024 /PRNewswire/ -- Citius Pharmaceuticals,...

Is Citius Pharma a Ten Bagger?

As is From $0.80 to $8.00.. One of our favorite Broker/Dealer Analysts thinks it is.. Positive news today from an old favorite Citius Pharma (CTXR),...

Bavarian Nordic (BVNRY) Bags $119 Million Order from Joe Biden.

We Were up 80% on Bavarian For a Little While There. The Stock Looks Better Today, Then When we Originally Added to Watch List....

Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy.

Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy I/ONTAK (E7777) for the Treatment of Persistent or Recurrent Cutaneous...
Revive Therapeutics $RVVTF

Amazing Sales of Paxlovid (CBS News).

"These medicines have a sweet spot. If the day you get diagnosed COVID you say 'forget it, I'll be fine,' and then several days...
Fuqua Professor David Ridley

Everything You Need to Know About FDA’s Priority Review Vouchers Worth $100’s of Millions.

Never Heard of These 'PRV's' but What a Potential Bonanza for the Recipients. They're transferable - as in they can be SOLD! https://youtu.be/ZwVC1PUvtXk David Riley, Duke...
Roland Rick Perry

Tax Loss Selling Bargain? Adding Aditxt (ADTX).

Adding Aditxt (ADTX) to the upcoming "2022 Biotech 6-Pack, Stocks We Expect to Double" Watch List. We're sitting in a hotel room in Chicago minding...

The Race to Develop Therapeutics for COVID. The Small Caps Fight for a Treatment...

The Second Wave: Biopharma Players Race to Develop Therapeutics for COVID-19 (BioSPace) December 21. Revive Therapeutics (RVTTF), RedHill BioPharma (RDHL), AI Pharma (Private), Apilli Thera...

Revive Therapeutics (RVVTF, RVV.CN) in Discussions to Secure Supply of 5 Billion Bucillamine Tablets.

Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 Not wanting to be caught flat-footed upon potential approval, Revive is...

Mitesco (MITI) Sets Opening Dates for New Minneapolis Clinics, Additional Sites in Minneapolis and...

MINNEAPOLIS, MN, Sept. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Mitesco, Inc. (OTCQB:MITI) ("Mitesco" or the "Company"), a leading operator of wellness clinics that combine...

Latest article

Churchill Capital (CCCX) Infleqtion Merger.

Interview with Quantum Computing - Infleqtion CEO Matt Kinsella “I personally believe quantum is going to be a very important technological shift for humanity over...

Get Ready: Gold Crash To $3,500, Bitcoin To Collapse 90% | Mike McGlone

https://youtu.be/ckZBaOOU2HM?si=ombBsU0caFKlRkEb

AI Powered Cyber Criminals Are Here. Are You Prepared?

15 Page Report on Sekur Private Data (SWISF) We've think we've come up with a way to make some money, and protect ourselves from AI...